SCHEMBL4756018

SCHEMBL4756018

Cc1ccc(S(=O)(=O)Oc2ccc(C(=O)Nc3nccs3)cc2)nc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.62
NPC1 O15118 6/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
HSD17B10 Q99714 2/20 0.57
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
POLB P06746 2/20 0.50
LMNA P02545 2/20 0.50
RECQL P46063 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
AGER Q15109 1/20 0.50
SCD O00767 1/20 0.48
ADORA2A P29274 4/20 0.47
MAPK1 P28482 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GBA1 P04062 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
MAPK10 P53779 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10113829 0.89 RAB9A (0.69) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL706414 0.81 RAB9A (0.71) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL3223685 0.79 RAB9A (1.00) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL15070451 0.76 RAB9A (0.73) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL28478360 0.75 RAB9A (1.00) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL404981 0.73 RAB9A (0.75) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL4756271 0.72 RAB9A (0.62) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL2753283 0.72 RAB9A (0.92) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL4295195 0.71 RAB9A (0.76) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL6227032 0.69 RAB9A (0.69) RAB9ANPC1SMN1; SMN2HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885NPC1 585/4885SMN1; SMN2 3410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.